Ieso Appoints Jo Parfrey as a Non-Executive Director
We are pleased to announce the appointment of Jo Parfrey to our Board of Directors as an independent Non-Executive Director. Jo is an accomplished Non-Executive Director, bringing healthcare sector experience and investment expertise to the boards of a broad spectrum of public and private companies over a two-decade period – including as a shareholder representative.
She currently sits as Non-Executive Director on the boards of Octopus AIM VCT plc, the venture capitalist trust, Henderson International Income Trust plc, Babraham Bioscience Technologies (BBT), the campus manager for one of the largest bioscience campuses in Europe, and Start Codon, the life sciences accelerator. For all of these organisations Jo sits on the Audit Committees – including as Chair at Henderson International Income Trust plc, BBT and Start Codon, where she is also a member of the additional investment advisory committee.
Throughout her career, Jo has held senior roles at the Board and Committee level, including at the following institutions: Guy’s and St Thomas’ Enterprise, Essentia Trading, and LGV Capital. At LGV Capital, Jo spent 11 years developing a strong investment portfolio, structuring and securing debt and equity financing, managing transactions, and supporting businesses through their growth and successful realisations. Jo is an ACA-qualified chartered accountant and holds a BA Hons in Chemistry from the University of Oxford.
Andy Richards, Chairman at Ieso said: “I am delighted that Jo has chosen to join the board of Ieso as an independent non-executive director. She brings deep experience of scale up in healthcare both as a board member and as an investment professional along with a strong understanding of corporate governance and compliance. She has an impressive track record of supporting both public and private businesses within the healthcare sector and in effecting transactions to accelerate growth I believe her expertise and approach to business excellence complements the capabilities of our current Board.”
On her appointment, Jo Parfrey said: “I am excited to be joining the Board of Ieso. I am keen to support dynamic businesses with a scale up agenda that offer a real-world contribution to benefit the wider population. Ieso’s mission and drive to revolutionise mental healthcare through its high-quality cognitive behavioural therapy service and impressive network of CCGs and NHS providers, aligns with my own passion to make a difference. I welcome the opportunity to collaborate with the team to drive forward the Company’s patient-centric ambitions for growth over the coming years.”
Nigel Pitchford, CEO at Ieso added: “The recent acceleration in adoption of digital health solutions has created significant growth opportunities for Ieso not only within the NHS, but also with care providers worldwide who recognise Ieso as delivering advanced evidence-based technologies that demonstrably improve the quality of mental healthcare provision. Jo’s strategic insights will be valuable to Ieso as we plot a course through this rapidly changing market.”